Corporate
Jun. 15, 2011
Alios Forms $1.5 Billion Partnership
Alios BioPharma Inc. could earn more than $1.5 billion from a collaboration with Vertex Pharmaceuticals Inc. to develop groundbreaking treatments for hepatitis C in one of the biotechnology industry's largest-ever partnerships.
Daily Journal Staff Writer
South San Francisco-based Alios BioPharma Inc. could earn more than $1.5 billion from a collaboration with Vertex Pharmaceuticals Inc. to develop groundbreaking treatments for hepatitis C in one of the biotechnology industry's largest-ever partnership deals.
John E. Wehrli, one of the partners from Latham & Watkins LLP who represented Alios in the transaction, said it is the largest partnersh...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In